The role of serum soluble CD40 ligand in diagnosis of acute coronary syndrome

Zhou Zhaoxia,Ma Aiqun,Qiang Hua,Zhou Ping,Cheng Hua
DOI: https://doi.org/10.3969/j.issn.1671-8259.2006.01.009
2006-01-01
Abstract:Objective To observe the changes of serum soluble segment of CD40 ligand(sCD40L)in patients with acute coronary syndrome(ACS),stable angina pectoris(SAP) and patients without coronary heart disease,and then evaluate the value of sCD40L in diagnosis of ACS.Methods Contents of sCD40L in serum were measured by chemiluminescent enzyme-linked immunosorbent assay from 77 patients with ACS(including 37 acute myocardial infarction and 40 unstable angina pectoris),42 patients with stable angina pectoris and 37 non-CHD patients who were all enrolled in our department during Apr.2002 to Dec.2003 or revisited during that period.And then serum sCD40L levels of each group was constrasted,and ROC curve was used to analyze the diagnostic value of sCD40L,TC,LDL and CK-MB in ACS.Results ①The ACS group had a higher serum sCD40L levels than SAP and non-CHD group(P<0.05);there was no significant difference between AMI and UAP patients(P>0.05),and neither between SAP and non-CHD patients(P>0.05).② On diagnosing ACS,the area under ROC curve of sCD40L was 0.773,the sensitivity,specificity and validity are 82.8%,61.9% and 85.7%,respectively,which were all highest among so much indexes.Conclusion High serum sCD40L levels may suggest vulnerable plaque,and it's somewhat valuable in diagnosing ACS.
What problem does this paper attempt to address?